Article Versions Notes

Lam AM, Dugyala RR, Sheraz M, Liu F, Thi EP, Graves IE, Cuconati A, Steuer HM, Ardzinski A, Overholt N, et al. Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161. Viruses. 2024; 16(3):323. https://doi.org/10.3390/v16030323

Lam, Angela M., Ravi R. Dugyala, Muhammed Sheraz, Fei Liu, Emily P. Thi, Ingrid E. Graves, Andrea Cuconati, Holly Micolochick Steuer, Andrzej Ardzinski, Nathan Overholt, and et al. 2024. "Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161" Viruses 16, no. 3: 323. https://doi.org/10.3390/v16030323

Lam, A. M., Dugyala, R. R., Sheraz, M., Liu, F., Thi, E. P., Graves, I. E., Cuconati, A., Steuer, H. M., Ardzinski, A., Overholt, N., Mason, J. D., Gotchev, D., Cole, A. G., Harasym, T. O., & Sofia, M. J. (2024). Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161. Viruses, 16(3), 323. https://doi.org/10.3390/v16030323